Robinson, K. M., Yang, W., Haidar, C. E., Hankins, J. S., Jay, D. W., Kornegay, N., . . . Relling, M. V. (2018). Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies. Pharmacogenomics J.
Chicago Style CitationRobinson, Katherine M., et al. "Concordance between Glucose-6-phosphate Dehydrogenase (G6PD) Genotype and Phenotype and Rasburicase Use in Patients With Hematologic Malignancies." Pharmacogenomics J 2018.
Cita MLARobinson, Katherine M., et al. "Concordance between Glucose-6-phosphate Dehydrogenase (G6PD) Genotype and Phenotype and Rasburicase Use in Patients With Hematologic Malignancies." Pharmacogenomics J 2018.
Atenció: Aquestes cites poden no estar 100% correctes.